KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Raw Materials (2016 - 2018)

Bausch Health Companies' Raw Materials history spans 7 years, with the latest figure at $275.0 million for Q4 2018.

  • On a quarterly basis, Raw Materials changed 0.36% to $275.0 million in Q4 2018 year-over-year; TTM through Dec 2018 was $275.0 million, a 0.36% change, with the full-year FY2018 number at $275.0 million, changed 0.36% from a year prior.
  • Raw Materials hit $275.0 million in Q4 2018 for Bausch Health Companies, down from $284.0 million in the prior quarter.
  • Over the last five years, Raw Materials for BHC hit a ceiling of $290.0 million in Q1 2018 and a floor of $191.1 million in Q4 2014.
  • Historically, Raw Materials has averaged $266.2 million across 5 years, with a median of $275.0 million in 2018.
  • Biggest five-year swings in Raw Materials: fell 13.84% in 2014 and later surged 51.23% in 2015.
  • Tracing BHC's Raw Materials over 5 years: stood at $191.1 million in 2014, then surged by 51.23% to $289.0 million in 2015, then decreased by 11.42% to $256.0 million in 2016, then grew by 7.81% to $276.0 million in 2017, then decreased by 0.36% to $275.0 million in 2018.
  • Business Quant data shows Raw Materials for BHC at $275.0 million in Q4 2018, $284.0 million in Q3 2018, and $274.0 million in Q2 2018.